Enhancer ID: | E_01_0058 |
Species: | human |
Position : | chr5:88714680-88716680 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Dilated cardiomyopathy |
Pubmed ID: | 28902616 |
Enhancer experiment: | Transfection,dual-luciferase reporter assay |
Enhancer experiment description: | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
TF name : | MEF2C(5430401D19Rik,9930028G15Rik,AV011172,Mef2) |
TF experiment: | Transfection,dual-luciferase reporter assay |
TF experiment description: | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
Enhancer function : | The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
The MADS-box transcription factor myocyte enhancer factor 2C (MEF2C) is required for the cardiac development and postnatal adaptation and in mice-targeted disruption of the MEF2C gene results in dilated cardiomyopathy (DCM). |
SNP ID: | -- |